CD4+ T-lymphocyte counts in HIV infection: Are European standards applicable to African patients?

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 4, 1997, Pages 361-367

  Anglaret, Xavier ^a   Diagbouga, Serge ^b   Mortier, Emmanuel ^c   Meda, Nicolas ^b   Vergé Valette, Véronique ^c   Sylla Koko, Fatoumata ^a   Consens, Simon ^e   Laruche, Guy ^a   Ledru, Eric ^b   Bonard, Dominique ^a   Dabis, François ^d   Van De Perre, Philippe ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^b CENTRE MURAZ   (Burkina Faso)

^c HÔPITAL SAINT ANTOINE   (France)

^d INSERM   (France)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa; CD4 count; Clinical management; Europe; Prophylaxis; Threshold CD4 count

Indexed keywords

CD4 ANTIGEN;

ADULT; AFRICA; ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; STANDARDIZATION; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS; JOTURUS PICHARDI;

EID: 12644300618     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199704010-00009     Document Type: Article

References (21)

1. Fahey J, Taylor J, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990;322:166-72.
2. Branson B. Early intervention for persons infected with human immunodeficiency virus, Clin Infect Dis 1995;20(suppl 1):3-22.
3. + lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. Arch Intern Med 1995; 155:1537-42.
4. Volberding PA, Lagakos SW, Grimes JM, et al. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. N Engl J Med 1995;333:401-7.
5. Anonymous. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWK Morb Mortal Wkly Rep 1994;43:1-20.
6. Anonymous. USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. Clin Infect Dis 1995; 21(suppl 1):12-31.
7. Jacobson MA, Bacchetti P, Kolokathis A, et al. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. Br Med J 1991;302:73-8.
8. Anonymous. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWK Morb Mortal Wkly Rep 1992;41:1-19.
9. Taylor JMG, Fahey JL, Detels R, Giorgi J. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to use and how to use. J AIDS 1989;2:114-24.
10. Mertens TE, Belsey E, Stoneburner RL, et al. Global estimates and epidemiology of HIV-1 infections and AIDS: further heterogeneity in spread and impact. AIDS 1995;9(suppl A): 259-72.
11. Brattegaard K, Kouadio J, Adorn ML, Doorly R, George JR, De Cock KM. Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in West Africa. AIDS 1993;7:883-5.
12. + T-cell determinations in persons with human immunodeficiency virus infection. MMWR Morb Mortal Wkly Rep 1992;41:1-17.
13. Koepke JA, Landay AL. Precision and accuracy of absolute lymphocyte counts. Clin Immunol Immunopathol 1989;52: 19-27.
14. Gilles HM. Normal haematological values in tropical areas. Clin Haematol 1981;10:697-706.
15. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
16. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373: 115-22.
17. Yarchoan R. Venzon DJ, Pluda JM, et al. CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 1991;115:184-9.
18. De Cock KM, Lucas SB, Lucas S, Agness J, Kadio A, Gayle HD. Clinical research, prophylaxis, therapy, and care for HIV disease in Africa. Am J Public Health 1993; 83:1385-9.
19. Anonymous. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWK Morb Mortal Wkly Rep 1991;44: 1-13.
20. Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA. Within-subject variation in CD4 lymphocyte counts in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J. Infect Dis 1994;169:28-36.
21. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.